000 | 01965 a2200529 4500 | ||
---|---|---|---|
005 | 20250517091755.0 | ||
264 | 0 | _c20170117 | |
008 | 201701s 0 0 eng d | ||
022 | _a1815-7920 | ||
024 | 7 |
_a10.5588/ijtld.15.0288 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMukherjee, A | |
245 | 0 | 0 |
_aPharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children. _h[electronic resource] |
260 |
_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cMay 2016 |
||
300 |
_a666-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAntitubercular Agents _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aChromatography, Liquid |
650 | 0 | 4 | _aCoinfection |
650 | 0 | 4 | _aDrug Dosage Calculations |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 |
_aEthambutol _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndia |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aIsoniazid _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPyrazinamide _xadministration & dosage |
650 | 0 | 4 |
_aRifampin _xadministration & dosage |
650 | 0 | 4 | _aSpectrometry, Mass, Electrospray Ionization |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTuberculosis _xblood |
700 | 1 | _aVelpandian, T | |
700 | 1 | _aSingla, M | |
700 | 1 | _aKanhiya, K | |
700 | 1 | _aKabra, S K | |
700 | 1 | _aLodha, R | |
773 | 0 |
_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 20 _gno. 5 _gp. 666-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5588/ijtld.15.0288 _zAvailable from publisher's website |
999 |
_c25931533 _d25931533 |